How to Tell Your Doctor You Cannot Afford Treatment
Cost is a constraint a doctor can plan around, and saying it early changes what gets built.
If you are wondering how to tell your doctor you cannot afford treatment, say it early and attach a number: "I can spend about $150 a month, and I need to know what is possible at that level." A budget is clinical information. It changes what gets prescribed and how often you are seen, and a clinic that can work with your number will tell you quickly.
Why is money harder to say out loud than a symptom?
Most people will describe an embarrassing rash to a clinician they met ninety seconds ago. Money takes them three visits.
Part of it is what we absorb about health being priceless. If health has no price, naming your ceiling can feel like admitting you value yourself at less than the treatment costs. That belief is heavy to carry into an exam room, and it is false.
Underneath sits a quieter fear: that a number, once said, becomes the whole plan. The opposite is usually true. A clinician who knows your ceiling stops guessing, and guessing is the expensive part.
I have written prescriptions that were never filled. I did not ask about cost, the patient did not volunteer it, and we both found out at the three-month visit, with the weight unmoved. That one is on me. Now I ask about money in the first ten minutes, before I write anything down.
So what do you actually say?
A number and a timeframe give a clinician something to work with. Saying money is tight is true for almost everyone and changes no decision on the page. Two sentences will do.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trial- Name your ceiling. "I can do about $150 a month for the next six months."
- Say what that has to cover. Medication only, or medication plus the visits and labs around it. People mean different things by the same number.
- Say when it changes. A bonus in March, or a second income restarting in the fall.
- Ask the direct question. "At that number, what is realistic, and what would you do if you were me?"
Raise it at the start of the visit. A budget mentioned in the doorway arrives after the plan is already written, and rebuilding takes longer than building around the constraint from the start.
You do not owe anyone an explanation of your finances. No clinician needs your household income or your debts. A ceiling and a date are enough.
How much of the cost can actually change?
More than most patients assume.
- Which molecule. Compounded semaglutide here is $499 for 90 days, or $166 a month, about $5.50 a day. Compounded tirzepatide starts at $699 for 90 days, $233 a month, about $7.70 a day. Compounded semaglutide and tirzepatide are not FDA-approved and are not identical to the brand versions, and the published trial figures describe the brand products: in the STEP trials (NEJM 2021), semaglutide 2.4 mg averaged 14.9 percent of body weight over 68 weeks alongside lifestyle changes, with about one in three participants reaching 20 percent or more, and SURMOUNT-1 (NEJM 2022) reported about 20.9 percent over 72 weeks at the highest studied tirzepatide dose. Results vary by individual. No trial compared the two under cost-driven stopping, so what follows is opinion rather than evidence: a medication you can keep paying for is usually the better place to start.
- Compounded or brand. Begin with what a brand product would actually cost you, since list price is rarely what a patient pays after manufacturer savings programs and coverage. Brand GLP-1 medications list around $968 to $1,349 a month before those programs. Ozempic and Wegovy are Novo Nordisk products; Mounjaro and Zepbound are Eli Lilly products, and this clinic is not affiliated with or endorsed by either company. Compounded semaglutide and tirzepatide are dispensed by state-licensed compounding pharmacies operating under section 503A after patient-specific and location-specific verification. Which route fits depends on your coverage, your dose, and your tolerance for supply variability.
- Dose pacing and follow-up. Some patients do well holding at a lower dose that costs less. If cost is pushing you there, say so, and let us make it the plan on purpose, with monitoring attached. Ask, too, which follow-ups exist for safety and which for convenience.
- The practical machinery. HSA and FSA funds are accepted here, and financing through Cherry, Klarna, or Affirm is available with terms set by the provider. Financing changes when you pay, so compare the total before you choose it.
- Starting smaller. The initial physician review is $119 one time and covers the doctor review and the prescription if approved, with medication billed separately. There is also a one-month introduction at $199 with the physician evaluation plus one month of compounded semaglutide, which is not FDA-approved and not identical to the brand version, and only if a prescription is approved and the dispensing pharmacy can fulfill it for your location. If the review finds you are not a candidate, the medication portion is refunded and the evaluation fee covers the work performed.
Back to that $150. On its own it does not reach the medication here, since the lowest option is $166 a month and the review is $119 one time. So the real conversation at $150 is about sequencing: which month absorbs the review fee, whether the one-month introduction is the right entry point, and what changes if the number can move to $170 by the fall.
Which parts of the plan cannot move?
The minimum required for safety.
Candidacy still has to be assessed honestly, and monitoring that is clinically indicated stays in the plan. Prescribing and shipping depend on where you are located, and that gets confirmed before any treatment decision. A pharmacy fills only what it can fill for your location, with packaging and shipping confirmed first.
No one can promise a guaranteed outcome honestly, and an evaluation trimmed to hit a price point is usually where the safety margin goes. Ask what the evaluation includes and who reviews it, before you pay for it.
What if you have to stop?
Tell us, and ask for a pause plan.
A pause plan is brief. What to expect for appetite and weight once the medication stops. What to do about protein and resistance training, since the goal is protecting muscle. What a restart looks like, including whether you return to titration. Whether a lower-cost bridge is medically reasonable for you.
Here is something we do not know yet: whether people who step down to a lower maintenance dose for cost reasons hold their results as well at five or ten years as those who stay at the studied dose. The long-term data do not exist. I say it out loud, because a plan resting on an assumption I kept to myself was never really theirs.
How should you read the answer you get?
Watch the ten seconds after you name your number, because that is where you learn how much room a practice has. A follow-up question means the conversation is live. A lower-cost option offered with the tradeoff explained means it is more than live.
If the answer is that the price is the price, that is often an honest report on a practice model set well above the exam room, by contract and institutional pricing. Either answer tells you where to bring the question next.
Plenty of clinicians raise cost themselves. When yours does, that is a good sign, and worth saying so. And if what comes back is a deadline instead of a plan, ask for the plan again.
Patients sometimes apologize for asking about money. There is nothing to apologize for. The plans I trust most are the ones built around a real number, because they were built for the life the patient actually has.
Write your number on the back of an envelope tonight. Bring it to the next appointment.
Frequently asked questions
Who do I talk to about cost if the price comes from the front desk?
Say it to the clinician as well. The person quoting a price often cannot change a clinical plan, and the person who can change the plan may never see the invoice. Give your number to whoever is writing the prescription, then ask the billing side what the quoted total includes and what gets billed separately.
Will naming a budget change how seriously I am taken?
Most clinicians treat a budget the way they treat any other constraint, like a work schedule or a fear of needles. You do not have to share income, debts, or reasons. If you want reassurance, ask for the plan and the monitoring schedule in writing, so you can see for yourself that nothing was quietly dropped.
Is the cheaper medication simply the weaker one?
Not necessarily for you. The trial averages do differ: about 14.9 percent of body weight over 68 weeks for semaglutide 2.4 mg alongside lifestyle changes (STEP, NEJM 2021), and about 20.9 percent over 72 weeks at the highest studied tirzepatide dose (SURMOUNT-1, NEJM 2022). Those trials studied the brand products. Compounded semaglutide and tirzepatide are not FDA-approved and are not identical to the brand versions, and results vary by individual. The dose you can stay on for a year matters more to you than the gap between two averages.
Is a brand GLP-1 ever the cheaper answer?
Sometimes, so check before you assume. Brand GLP-1 medications list around $968 to $1,349 a month before manufacturer programs, and a savings program or existing coverage can move that number a long way. Ozempic and Wegovy are Novo Nordisk products; Mounjaro and Zepbound are Eli Lilly products, and New Hope Weight Loss and Wellness is not affiliated with or endorsed by either company.
What if my budget changes in the middle of treatment?
Bring it up at the next visit, before a refill has been skipped. A raise, a layoff, or a bill landing in March all change how a plan should be sequenced, and it can be rebuilt around the new number. HSA and FSA funds are accepted, and Cherry, Klarna, and Affirm financing is available on terms the provider sets.
Clinical evidence
The trial figures cited in this article come from randomized trials of the FDA-approved brand products, not from compounded preparations. Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and individual results vary.
- SURMOUNT-1 trial (tirzepatide): N Engl J Med. 2022;387:205-216. PubMed
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.